{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:43:39Z","timestamp":1790613819192,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Plasmodium falciparum<\/jats:italic>\n                    erythrocyte membrane protein 1 (PfEMP1) family members mediate receptor- and tissue-specific sequestration of infected erythrocytes (IEs) in malaria. Antibody responses are a central component of naturally acquired malaria immunity. PfEMP1-specific IgG likely protects by inhibiting IE sequestration and through IgG-Fc Receptor (Fc\u03b3R) mediated phagocytosis and killing of antibody-opsonized IEs. The affinity of afucosylated IgG to Fc\u03b3RIIIa is up to 40-fold higher than fucosylated IgG, resulting in enhanced antibody-dependent cellular cytotoxicity. Most IgG in plasma is fully fucosylated, but afucosylated IgG is elicited in response to enveloped viruses and to paternal alloantigens during pregnancy. Here we show that naturally acquired PfEMP1-specific IgG is strongly afucosylated in a stable and exposure-dependent manner, and efficiently induces Fc\u03b3RIIIa-dependent natural killer (NK) cell degranulation. In contrast, immunization with a subunit PfEMP1 (VAR2CSA) vaccine results in fully fucosylated specific IgG. These results have implications for understanding protective natural- and vaccine-induced immunity to malaria.\n                  <\/jats:p>","DOI":"10.1038\/s41467-021-26118-w","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T09:52:53Z","timestamp":1633427573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Afucosylated Plasmodium falciparum-specific IgG is induced by infection but not by subunit vaccination"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1985-5901","authenticated-orcid":false,"given":"Mads Delbo","family":"Larsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9876-0248","authenticated-orcid":false,"given":"Mary","family":"Lopez-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel Kakra","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Ampomah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicaise","family":"Tuikue Ndam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Nouta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolien A. M.","family":"Koeleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1689-0442","authenticated-orcid":false,"given":"Agnes L. Hipgrave","family":"Ederveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Mordm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2207-5575","authenticated-orcid":false,"given":"Ali","family":"Salanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2668-4992","authenticated-orcid":false,"given":"Morten Agertoug","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achille","family":"Massougbodji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Ellen","family":"van der Schoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Ofori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0814-4995","authenticated-orcid":false,"given":"Manfred","family":"Wuhrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1698-4927","authenticated-orcid":false,"given":"Lars","family":"Hviid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5621-003X","authenticated-orcid":false,"given":"Gestur","family":"Vidarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,5]]},"reference":[{"key":"26118_CR1","unstructured":"World Health Organization. World Malaria Report 2020 (2020)."},{"key":"26118_CR2","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4049\/jimmunol.1202578","volume":"190","author":"A Bengtsson","year":"2013","unstructured":"Bengtsson, A. et al. A novel domain cassette identifies Plasmodium falciparum PfEMP1 proteins binding ICAM-1 and is a target of cross-reactive, adhesion-inhibitory antibodies. J. Immunol. 190, 240\u2013249 (2013).","journal-title":"J. Immunol."},{"key":"26118_CR3","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1126\/science.272.5267.1502","volume":"272","author":"M Fried","year":"1996","unstructured":"Fried, M. & Duffy, P. E. Adherence of Plasmodium falciparum to chondroitin sulphate A in the human placenta. Science 272, 1502\u20131504 (1996).","journal-title":"Science"},{"key":"26118_CR4","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nature12216","volume":"498","author":"L Turner","year":"2013","unstructured":"Turner, L. et al. Severe malaria is associated with parasite binding to endothelial protein C receptor. Nature 498, 502\u2013505 (2013).","journal-title":"Nature"},{"key":"26118_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/bs.apar.2015.02.004","volume":"88","author":"L Hviid","year":"2015","unstructured":"Hviid, L. & Jensen, A. T. PfEMP1\u2014a parasite protein family of key importance in Plasmodium falciparum malaria immunity and pathogenesis. Adv. Parasitol. 88, 51\u201384 (2015).","journal-title":"Adv. Parasitol."},{"key":"26118_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S1473-3099(07)70022-1","volume":"7","author":"SJ Rogerson","year":"2007","unstructured":"Rogerson, S. J., Hviid, L., Duffy, P. E., Leke, R. F. G. & Taylor, D. W. Malaria in pregnancy: pathogenesis and immunity. Lancet Infect. Dis. 7, 105\u2013117 (2007).","journal-title":"Lancet Infect. Dis."},{"key":"26118_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/imr.12807","volume":"293","author":"AR Jensen","year":"2020","unstructured":"Jensen, A. R., Adams, Y. & Hviid, L. Cerebral Plasmodium falciparum malaria: the role of PfEMP1 in its pathogenesis and immunity, and PfEMP1-based vaccines to prevent it. Immunol. Rev. 293, 230\u2013252 (2020).","journal-title":"Immunol. Rev."},{"key":"26118_CR8","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1084\/jem.20040274","volume":"199","author":"ATR Jensen","year":"2004","unstructured":"Jensen, A. T. R. et al. Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by Group A var genes. J. Exp. Med. 199, 1179\u20131190 (2004).","journal-title":"J. Exp. Med."},{"key":"26118_CR9","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1084\/jem.20041579","volume":"200","author":"A Salanti","year":"2004","unstructured":"Salanti, A. et al. Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. J. Exp. Med. 200, 1197\u20131203 (2004).","journal-title":"J. Exp. Med"},{"key":"26118_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1086\/430933","volume":"192","author":"NG Tuikue Ndam","year":"2005","unstructured":"Tuikue Ndam, N. G. et al. High level of var2csa transcription by Plasmodium falciparum isolated from the placenta. J. Infect. Dis. 192, 331\u2013335 (2005).","journal-title":"J. Infect. Dis."},{"key":"26118_CR11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/192733a0","volume":"192","author":"S Cohen","year":"1961","unstructured":"Cohen, S., McGregor, I. A. & Carrington, S. Gammaglobulin and acquired immunity to human malaria. Nature 192, 733\u2013737 (1961).","journal-title":"Nature"},{"key":"26118_CR12","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/76272","volume":"6","author":"DJ Conway","year":"2000","unstructured":"Conway, D. J. et al. A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat. Med. 6, 689\u2013692 (2000).","journal-title":"Nat. Med."},{"key":"26118_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1615","volume":"2","author":"AD Douglas","year":"2011","unstructured":"Douglas, A. D. et al. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. Nat. Commun. 2, 601 (2011).","journal-title":"Nat. Commun."},{"key":"26118_CR14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/infdis\/jiw617","volume":"215","author":"IH Kana","year":"2017","unstructured":"Kana, I. H. et al. Naturally acquired antibodies target the glutamate-rich protein on intact merozoites and predict protection against febrile malaria. J. Infect. Dis. 215, 623\u2013630 (2017).","journal-title":"J. Infect. Dis."},{"key":"26118_CR15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1086\/315652","volume":"182","author":"PC Bull","year":"2000","unstructured":"Bull, P. C. et al. Plasmodium falciparum-infected erythrocytes: agglutination by diverse Kenyan plasma is associated with severe disease and young host age. J. Infect. Dis. 182, 252\u2013259 (2000).","journal-title":"J. Infect. Dis."},{"key":"26118_CR16","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1128\/IAI.00593-10","volume":"78","author":"GK Cham","year":"2010","unstructured":"Cham, G. K. et al. Hierarchical, domain type-specific acquisition of antibodies to Plasmodium falciparum erythrocyte membrane protein 1 in Tanzanian children. Infect. Immun. 78, 4653\u20134659 (2010).","journal-title":"Infect. Immun."},{"key":"26118_CR17","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/infdis\/jix530","volume":"216","author":"C Schmiegelow","year":"2017","unstructured":"Schmiegelow, C. et al. Plasmodium falciparum infection early in pregnancy has profound consequences for fetal growth. J. Infect. Dis. 216, 1601\u20131610 (2017).","journal-title":"J. Infect. Dis."},{"key":"26118_CR18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/infdis\/jiy168","volume":"218","author":"MF Ofori","year":"2018","unstructured":"Ofori, M. F., Lamptey, H., Dickson, E. K., Kyei-Baafour, E. & Hviid, L. Etiology of placental Plasmodium falciparum malaria in African women. J. Infect. Dis. 218, 277\u2013281 (2018).","journal-title":"J. Infect. Dis."},{"key":"26118_CR19","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/sj.embor.7400466","volume":"6","author":"NK Viebig","year":"2005","unstructured":"Viebig, N. K. et al. A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A. EMBO Rep. 6, 775\u2013781 (2005).","journal-title":"EMBO Rep."},{"key":"26118_CR20","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1086\/500146","volume":"193","author":"NG Tuikue Ndam","year":"2006","unstructured":"Tuikue Ndam, N. G. et al. Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of Senegalese pregnant women. J. Infect. Dis. 193, 713\u2013720 (2006).","journal-title":"J. Infect. Dis."},{"key":"26118_CR21","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/27570","volume":"395","author":"M Fried","year":"1998","unstructured":"Fried, M., Nosten, F., Brockman, A., Brabin, B. T. & Duffy, P. E. Maternal antibodies block malaria. Nature 395, 851\u2013852 (1998).","journal-title":"Nature"},{"key":"26118_CR22","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.4049\/jimmunol.165.6.3309","volume":"165","author":"CH Ricke","year":"2000","unstructured":"Ricke, C. H. et al. Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on Plasmodium falciparum-infected erythrocytes in a parity-dependent manner and block parasite adhesion to chondroitin sulphate A. J. Immunol. 165, 3309\u20133316 (2000).","journal-title":"J. Immunol."},{"key":"26118_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(03)15386-X","volume":"363","author":"T Staalsoe","year":"2004","unstructured":"Staalsoe, T. et al. Variant surface antigen-specific IgG and protection against the clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Lancet 363, 283\u2013289 (2004).","journal-title":"Lancet"},{"key":"26118_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1006\/expr.1998.4368","volume":"91","author":"KP Piper","year":"1999","unstructured":"Piper, K. P., Roberts, D. J. & Day, K. P. Plasmodium falciparum: analysis of the antibody specificity to the surface of the trophozoite-infected erythrocyte. Exp. Parasitol. 91, 161\u2013169 (1999).","journal-title":"Exp. Parasitol."},{"key":"26118_CR25","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.1128\/IAI.73.7.4112-4118.2005","volume":"73","author":"R Megnekou","year":"2005","unstructured":"Megnekou, R., Staalsoe, T., Taylor, D. W., Leke, R. & Hviid, L. Effects of pregnancy and intensity of Plasmodium falciparum transmission on immunoglobulin G subclass responses to variant surface antigens. Infect. Immun. 73, 4112\u20134118 (2005).","journal-title":"Infect. Immun."},{"key":"26118_CR26","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.3389\/fimmu.2018.03088","volume":"9","author":"MD Larsen","year":"2019","unstructured":"Larsen, M. D. et al. Evasion of classical complement pathway activation on Plasmodium falciparum-infected erythrocytes opsonized by PfEMP1-specific IgG. Front. Immunol. 9, 3088 (2019).","journal-title":"Front. Immunol."},{"key":"26118_CR27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0035-9203(89)90478-1","volume":"83","author":"K Marsh","year":"1989","unstructured":"Marsh, K., Otoo, L., Hayes, R. J., Carson, D. C. & Greenwood, B. M. Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans. R. Soc. Trop. Med. Hyg. 83, 293\u2013303 (1989).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"26118_CR28","doi-asserted-by":"publisher","first-page":"e22491","DOI":"10.1371\/journal.pone.0022491","volume":"6","author":"R Ataide","year":"2011","unstructured":"Ataide, R., Mwapasa, V., Molyneux, M. E., Meshnick, S. R. & Rogerson, S. J. Antibodies that induce phagocytosis of malaria infected erythrocytes: effect of HIV infection and correlation with clinical outcomes. PLoS ONE 6, e22491 (2011).","journal-title":"PLoS ONE"},{"key":"26118_CR29","doi-asserted-by":"publisher","first-page":"e36806","DOI":"10.7554\/eLife.36806","volume":"7","author":"G Arora","year":"2018","unstructured":"Arora, G. et al. NK cells inhibit Plasmodium falciparum growth in red blood cells via antibody-dependent cellular cytotoxicity. Elife 7, e36806 (2018).","journal-title":"Elife"},{"key":"26118_CR30","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1084\/jem.170.2.481","volume":"170","author":"JV Ravetch","year":"1989","unstructured":"Ravetch, J. V. & Perussia, B. Alternative membrane forms of FcgRIII (CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J. Exp. Med 170, 481\u2013497 (1989).","journal-title":"J. Exp. Med"},{"key":"26118_CR31","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","volume":"5","author":"G Vidarsson","year":"2014","unstructured":"Vidarsson, G., Dekkers, G. & Rispens, T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 5, 520 (2014).","journal-title":"Front Immunol."},{"key":"26118_CR32","doi-asserted-by":"publisher","first-page":"12669","DOI":"10.1073\/pnas.1108455108","volume":"108","author":"C Ferrara","year":"2011","unstructured":"Ferrara, C. et al. Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgRIII and antibodies lacking core fucose. Proc. Natl Acad. Sci. USA 108, 12669\u201312674 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"26118_CR33","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1126\/science.aai8128","volume":"355","author":"TT Wang","year":"2017","unstructured":"Wang, T. T. et al. IgG antibodies to dengue enhanced for FcgRIIIA binding determine disease severity. Science 355, 395\u2013398 (2017).","journal-title":"Science"},{"key":"26118_CR34","doi-asserted-by":"publisher","first-page":"eabc8378","DOI":"10.1126\/science.abc8378","volume":"371","author":"MD Larsen","year":"2021","unstructured":"Larsen, M. D. et al. Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity. Science 371, eabc8378 (2021).","journal-title":"Science"},{"key":"26118_CR35","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3389\/fimmu.2017.00877","volume":"8","author":"G Dekkers","year":"2017","unstructured":"Dekkers, G. et al. Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of Fc-receptor- and complement-mediated-effector activities. Front. Immunol. 8, 877 (2017).","journal-title":"Front. Immunol."},{"key":"26118_CR36","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.4049\/jimmunol.1900985","volume":"203","author":"AR Temming","year":"2019","unstructured":"Temming, A. R. et al. Functional attributes of antibodies, effector cells, and target cells affecting NK cell-mediated antibody-dependent cellular cytotoxicity. J. Immunol. 203, 3126\u20133135 (2019).","journal-title":"J. Immunol."},{"key":"26118_CR37","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1021\/acs.jproteome.6b00038","volume":"15","author":"N de Haan","year":"2016","unstructured":"de Haan, N., Reiding, K. R., Driessen, G., van der Burg, M. & Wuhrer, M. Changes in healthy human IgG Fc-glycosylation after birth and during early childhood. J. Proteome Res. 15, 1853\u20131861 (2016).","journal-title":"J. Proteome Res."},{"key":"26118_CR38","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1021\/pr300887z","volume":"12","author":"MP Bakovic","year":"2013","unstructured":"Bakovic, M. P. et al. High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides. J. Proteome Res. 12, 821\u2013831 (2013).","journal-title":"J. Proteome Res."},{"key":"26118_CR39","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1021\/pr800651j","volume":"8","author":"M Wuhrer","year":"2009","unstructured":"Wuhrer, M. et al. Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens. J. Proteome Res. 8, 450\u2013456 (2009).","journal-title":"J. Proteome Res."},{"key":"26118_CR40","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/bjh.12965","volume":"166","author":"R Kapur","year":"2014","unstructured":"Kapur, R. et al. Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn. Br. J. Haematol. 166, 936\u2013945 (2014).","journal-title":"Br. J. Haematol."},{"key":"26118_CR41","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/bjh.14053","volume":"174","author":"ME Sonneveld","year":"2016","unstructured":"Sonneveld, M. E. et al. Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia. Br. J. Haematol. 174, 310\u2013320 (2016).","journal-title":"Br. J. Haematol."},{"key":"26118_CR42","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1172\/JCI65708","volume":"123","author":"ME Ackerman","year":"2013","unstructured":"Ackerman, M. E. et al. Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. J. Clin. Invest. 123, 2183\u20132192 (2013).","journal-title":"J. Clin. Invest."},{"key":"26118_CR43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41590-020-00828-7","volume":"22","author":"S Chakraborty","year":"2021","unstructured":"Chakraborty, S. et al. Proinflammatory IgG Fc structures in patients with severe COVID-19. Nat. Immunol. 22, 67\u201373 (2021).","journal-title":"Nat. Immunol."},{"key":"26118_CR44","doi-asserted-by":"publisher","first-page":"014563","DOI":"10.1074\/mcp.M111.014563","volume":"11","author":"MH Selman","year":"2012","unstructured":"Selman, M. H. et al. Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination. Mol. Cell Proteomics 11, 014563 (2012). M111.","journal-title":"Mol. Cell Proteomics"},{"key":"26118_CR45","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/iid3.22","volume":"2","author":"AC Vestrheim","year":"2014","unstructured":"Vestrheim, A. C. et al. A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines. Immun. Inflamm. Dis. 2, 76\u201391 (2014).","journal-title":"Immun. Inflamm. Dis."},{"key":"26118_CR46","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1182\/blood-2013-09-527978","volume":"123","author":"R Kapur","year":"2014","unstructured":"Kapur, R. et al. A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy. Blood 123, 471\u2013480 (2014).","journal-title":"Blood"},{"key":"26118_CR47","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/bjh.14438","volume":"176","author":"ME Sonneveld","year":"2017","unstructured":"Sonneveld, M. E. et al. Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn. Br. J. Haematol. 176, 651\u2013660 (2017).","journal-title":"Br. J. Haematol."},{"key":"26118_CR48","first-page":"13","volume":"43","author":"M Ofori","year":"2009","unstructured":"Ofori, M. et al. Pregnancy-associated malaria in a rural community of Ghana. Ghana Med. J. 43, 13\u201318 (2009).","journal-title":"Ghana Med. J."},{"key":"26118_CR49","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0166-6851(91)90135-S","volume":"49","author":"MB Borre","year":"1991","unstructured":"Borre, M. B. et al. Primary structure and localization of a conserved immunogenic Plasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate lifecycle. Mol. Biochem. Parasitol. 49, 119\u2013132 (1991).","journal-title":"Mol. Biochem. Parasitol."},{"key":"26118_CR50","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.actatropica.2009.08.017","volume":"112","author":"NW Awah","year":"2009","unstructured":"Awah, N. W., Troye-Blomberg, M., Berzins, K. & Gysin, J. Mechanisms of malarial anaemia: potential involvement of the Plasmodium falciparum low molecular weight rhoptry-associated proteins. Acta Trop. 112, 295\u2013302 (2009).","journal-title":"Acta Trop."},{"key":"26118_CR51","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.4049\/jimmunol.168.7.3444","volume":"168","author":"MA Nielsen","year":"2002","unstructured":"Nielsen, M. A. et al. Plasmodium falciparum variant surface antigen expression varies between isolates causing severe and non-severe malaria and is modified by acquired immunity. J. Immunol. 168, 3444\u20133450 (2002).","journal-title":"J. Immunol."},{"key":"26118_CR52","first-page":"e00622","volume":"86","author":"RW Olsen","year":"2018","unstructured":"Olsen, R. W. et al. Natural and vaccine-induced acquisition of cross-reactive IgG-inhibiting ICAM-1-specific binding of a Plasmodium falciparum PfEMP1 subtype associated specifically with cerebral malaria. Infect. Immun. 86, e00622\u201300617 (2018).","journal-title":"Infect. Immun."},{"key":"26118_CR53","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1128\/IAI.01514-13","volume":"82","author":"P Ampomah","year":"2014","unstructured":"Ampomah, P., Stevenson, L., Ofori, M. F., Barfod, L. & Hviid, L. B-cell responses to pregnancy-restricted and -unrestricted Plasmodium falciparum erythrocyte membrane protein 1 antigens in Ghanaian women naturally exposed to malaria parasites. Infect. Immun. 82, 1860\u20131871 (2014).","journal-title":"Infect. Immun."},{"key":"26118_CR54","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1086\/322809","volume":"184","author":"T Staalsoe","year":"2001","unstructured":"Staalsoe, T. et al. Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum infected erythrocytes that are associated with protection against placental parasitemia. J. Infect. Dis. 184, 618\u2013626 (2001).","journal-title":"J. Infect. Dis."},{"key":"26118_CR55","doi-asserted-by":"publisher","first-page":"5236","DOI":"10.4049\/jimmunol.1400325","volume":"192","author":"P Ampomah","year":"2014","unstructured":"Ampomah, P., Stevenson, L., Ofori, M. F., Barfod, L. & Hviid, L. Kinetics of B cell responses to Plasmodium falciparum erythrocyte membrane protein 1 in Ghanaian women naturally exposed to malaria parasites. J. Immunol. 192, 5236\u20135244 (2014).","journal-title":"J. Immunol."},{"key":"26118_CR56","doi-asserted-by":"publisher","first-page":"6620","DOI":"10.1128\/IAI.71.11.6620-6623.2003","volume":"71","author":"PE Duffy","year":"2003","unstructured":"Duffy, P. E. & Fried, M. Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns. Infect. Immun. 71, 6620\u20136623 (2003).","journal-title":"Infect. Immun."},{"key":"26118_CR57","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1086\/381186","volume":"189","author":"JG Beeson","year":"2004","unstructured":"Beeson, J. G. et al. Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes and adhesion inhibitory antibodies are associated with placental malaria and have overlapping and distinct targets. J. Infect. Dis. 189, 540\u2013551 (2004).","journal-title":"J. Infect. Dis."},{"key":"26118_CR58","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.jmb.2010.01.040","volume":"397","author":"P Khunrae","year":"2010","unstructured":"Khunrae, P. et al. Full-length recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion-blocking antibodies. J. Mol. Biol. 397, 826\u2013834 (2010).","journal-title":"J. Mol. Biol."},{"key":"26118_CR59","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.1073\/pnas.1000951107","volume":"107","author":"A Srivastava","year":"2010","unstructured":"Srivastava, A. et al. Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA. Proc. Natl Acad. Sci. USA 107, 4884\u20134889 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"26118_CR60","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/cid\/ciy1140","volume":"69","author":"B Mordmuller","year":"2019","unstructured":"Mordmuller, B. et al. First-in-human, randomized, double-blind clinical trial of differentially adjuvanted PAMVAC, a vaccine candidate to prevent pregnancy-associated malaria. Clin. Infect. Dis. 69, 1509\u20131516 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"26118_CR61","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S1473-3099(19)30739-X","volume":"20","author":"SB Sirima","year":"2020","unstructured":"Sirima, S. B. et al. PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study. Lancet Infect. Dis. 20, 585\u2013597 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"26118_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/srep28207","volume":"6","author":"SE de Jong","year":"2016","unstructured":"de Jong, S. E. et al. IgG1 Fc N-glycan galactosylation as a biomarker for immune activation. Sci. Rep. 6, 28207 (2016).","journal-title":"Sci. Rep."},{"key":"26118_CR63","first-page":"312","volume":"2","author":"EA Afari","year":"1995","unstructured":"Afari, E. A., Appawu, M., Dunyo, S., Baffoe-Wilmot, A. & Nkrumah, F. K. Malaria infection, morbidity and transmission in two ecological zones in southern Ghana. Afr. J. Health Sci. 2, 312\u2013316 (1995).","journal-title":"Afr. J. Health Sci."},{"key":"26118_CR64","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/cmi.12403","volume":"17","author":"L Stevenson","year":"2015","unstructured":"Stevenson, L. et al. Investigating the function of Fc-specific binding of IgM to Plasmodium falciparum erythrocyte membrane protein 1 mediating erythrocyte rosetting. Cell Microbiol. 17, 819\u2013831 (2015).","journal-title":"Cell Microbiol"},{"key":"26118_CR65","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1128\/cdli.2.1.30-34.1995","volume":"2","author":"M Theisen","year":"1995","unstructured":"Theisen, M., Vuust, J., Gottschau, A., Jepsen, S. & Hogh, B. Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli. Clin. Diagn. Lab Immunol. 2, 30\u201334 (1995).","journal-title":"Clin. Diagn. Lab Immunol."},{"key":"26118_CR66","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1365-2958.2006.05503.x","volume":"63","author":"L Barfod","year":"2007","unstructured":"Barfod, L. et al. Human pregnancy-associated malaria-specific B cells target polymorphic, conformational epitopes in VAR2CSA. Mol. Micobiol. 63, 335\u2013347 (2007).","journal-title":"Mol. Micobiol."},{"key":"26118_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/srep36964","volume":"6","author":"G Dekkers","year":"2016","unstructured":"Dekkers, G. et al. Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans. Sci. Rep. 6, 36964 (2016).","journal-title":"Sci. Rep."},{"key":"26118_CR68","doi-asserted-by":"publisher","first-page":"e00136","DOI":"10.1128\/IAI.00136-18","volume":"86","author":"M Lopez-Perez","year":"2018","unstructured":"Lopez-Perez, M. et al. IgG responses to the Plasmodium falciparum antigen VAR2CSA in Colombia are restricted to pregnancy and are not induced by exposure to Plasmodium vivax. Infect. Immun. 86, e00136\u201300118 (2018).","journal-title":"Infect. Immun."},{"key":"26118_CR69","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.4049\/jimmunol.1201574","volume":"190","author":"S Jegaskanda","year":"2013","unstructured":"Jegaskanda, S. et al. Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies. J. Immunol. 190, 1837\u20131848 (2013).","journal-title":"J. Immunol."},{"key":"26118_CR70","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.3389\/fimmu.2018.02873","volume":"9","author":"KM Snyder","year":"2018","unstructured":"Snyder, K. M. et al. Expression of a recombinant high affinity IgG Fc receptor by engineered NK cells as a docking platform for therapeutic mAbs to target cancer cells. Front. Immunol. 9, 2873 (2018).","journal-title":"Front. Immunol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26118-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26118-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26118-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T10:48:41Z","timestamp":1669978121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26118-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,5]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["26118"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-26118-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.04.23.441082","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,5]]},"assertion":[{"value":"24 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5838"}}